Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)

NCT03159884 is registered in ClinicalTrials.gov with Chengdu Kanghong Biotech Co., Ltd. as lead sponsor.

NCT NCT03159884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
Lead sponsor
Chengdu Kanghong Biotech Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2015
Completion date
December 31, 2018
Enrollment
300 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy (pcv)